(Q38998171)

8 September 2017

1 reference

title

Thyroid hormones and cardiovascular disease (English)

1 reference

8 September 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27811932%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Avais Jabbar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27811932%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Alessandro Pingitore

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27811932%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Azfar Zaman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27811932%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Giorgio Iervasi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27811932%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Salman Razvi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27811932%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

English

0 references

publication date

4 November 2016

1 reference

Nature Reviews Cardiology

8 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27811932%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27811932%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27811932%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

39-55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27811932%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular disease in Europe - epidemiological update 2015

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone and the cardiovascular system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Diagnosis and treatment of primary hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Subclinical thyroid dysfunction as a risk factor for cardiovascular disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid status, cardiovascular risk, and mortality in older adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The Colorado thyroid disease prevalence study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

On Myxœdema, a Term Proposed to Be Applied to an Essential Condition in the “Cretinoid” Affection Occasionally Observed in Middle-Aged Women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Note on the Treatment of Myx dema by Hypodermic Injections of an Extract of the Thyroid Gland of a Sheep

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The discovery of thyroid replacement therapy. Part 3: A complete transformation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Prophylaxis of ischaemic heart-disease by thyroid therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

On the genesis of atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

RADIOIMMUNOASSAY OF HUMAN PLASMA THYROTROPIN.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Coronary-artery disease in myxoedema

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Coronary-artery disease in hypothyroidism. Observations in clinical myxoedema

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The spectrum of thyroid disease in a community: the Whickham survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Potential therapeutic applications of thyroid hormone analogs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Acute myocardial infarction and thyroid function: new pathophysiological and therapeutic perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone action: in vitro characterization of solubilized nuclear receptors from rat liver and cultured GH1 cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Left-ventricular remodeling after myocardial infarction is associated with a cardiomyocyte-specific hypothyroid condition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Subclinical thyroid disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Mechanisms of thyroid hormone action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Molecular aspects of thyroid hormone actions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The molecular basis of thyroid hormone action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone control of contraction and the Ca(2+)-ATPase/phospholamban complex in adult rat ventricular myocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormones increase the contractility but suppress the effects of beta-adrenergic agonist by decreasing phospholamban expression in rat atria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Effects of thyroid hormone on the cardiovascular system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Acute effects of thyroid hormone on vascular smooth muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone activates Akt and prevents serum starvation-induced cell death in neonatal rat cardiomyocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone and myocardial mitochondrial biogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Levothyroxine improves abnormal cardiac bioenergetics in subclinical hypothyroidism: a cardiac magnetic resonance spectroscopic study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone control of thermogenesis and energy balance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Myocardial mechanics in hyperthyroidism: importance of left ventricular loading conditions, heart rate and contractile state

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone treatment after coronary-artery bypass surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

PLasma renin activity in syndromes of thyroid hormone excess and deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Management of atrial fibrillation in the post-thyrotoxic state

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Mechanisms in endocrinology: Heart failure and thyroid dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid function and mortality in patients treated for hyperthyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Subclinical thyroid disease: scientific review and guidelines for diagnosis and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The clinical significance of subclinical thyroid dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Adequacy of thyroid hormone replacement in a general population.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid function and left ventricular structure and function in the Framingham Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Subclinical hyperthyroidism is not associated with progression of cardiac mass and development of left ventricular hypertrophy in middle-aged and older subjects: results from a 5-year follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid Function and Carotid Wall Thickness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Low serum thyrotropin is associated with high plasma fibrinogen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Association between increased mortality and mild thyroid dysfunction in cardiac patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Subclinical hyperthyroidism and atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Association between serum free thyroxine concentration and atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Subclinical hyperthyroidism and the risk of coronary heart disease and mortality.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Normal Thyroid Function and the Risk of Atrial Fibrillation: the Rotterdam Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid function in the euthyroid range and adverse outcomes in older adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone concentrations, disease, physical function, and mortality in elderly men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid disease and the heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Hypothyroidism and atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Cardiovascular and atherogenic aspects of subclinical hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid disease and vascular function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Subclinical hypothyroidism and the risk of coronary heart disease and mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid disease and vascular risk.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

2013 ETA Guideline: Management of Subclinical Hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Circulating lipids and minor abnormalities of thyroid function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid disease and lipids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Effects of Subclinical Hypothyroidism and Its Treatment on Serum Lipids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Subclinical hypothyroidism and the risk of hypercholesterolemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone and blood pressure regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Subclinical hyperthyroidism and blood pressure in a population-based prospective cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Blood pressure levels in patients with subclinical thyroid dysfunction: a meta-analysis of cross-sectional data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The association between subclinical hyperthyroidism and blood pressure in a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Subclinical thyroid dysfunction and blood pressure: a community-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Hypothyroidism as a cause of hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Blood pressure in relation to serum thyrotropin: The Tromsø study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Aortic distensibility in patients with isolated hypercholesterolaemia, coronary artery disease, or cardiac transplant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Effects of thyroid replacement therapy on arterial blood pressure in patients with hypertension and hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Increased central arterial stiffness in hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Increased pulse wave velocity in subclinical hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Changes in brachial-ankle pulse wave velocity in subclinical hypothyroidism during normalization of thyroid function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Decrease of brachial-ankle pulse wave velocity in female subclinical hypothyroid patients during normalization of thyroid function: a double-blind, placebo-controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Endothelial function: cardiac events

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Evaluation of endothelial function in subclinical hypothyroidism and subclinical hyperthyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Expression of vascular adhesion molecules on human endothelia in autoimmune thyroid disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

In vivo selective expression of thyroid hormone receptor α1 in endothelial cells attenuates myocardial injury in experimental myocardial infarction in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Early coronary angiogenesis in response to thyroxine: growth characteristics and upregulation of basic fibroblast growth factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Hyperthyroidism and venous thrombosis: a casual or causal association? A systematic literature review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The association of thyroid function with carotid artery plaque burden and strokes in a population-based sample from a previously iodine-deficient area.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Blood thrombogenicity is independently associated with serum TSH levels in post-non-ST elevation acute coronary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid diseases and cerebrovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Acquired von Willebrand syndrome--report of 10 cases and review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone substitution therapy rapidly enhances left-ventricular diastolic function in hypothyroid patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Changes in cardiac function at rest before and after treatment in primary hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Early textural and functional alterations of left ventricular myocardium in mild hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Effects of thyroxin therapy on cardiac function in patients with subclinical hypothyroidism: index of myocardial performance in the evaluation of left ventricular function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Type 3 deiodinase in hypoxia: to cool or to kill?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Developing thyroid disorders is associated with poor prognosis factors in patient with stable chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Triiodothyronine levels for risk stratification of patients with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The effects of acute triiodothyronine therapy on myocardial gene expression in brain stem dead cardiac donors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Long-term L-Triiodothyronine (T3) treatment in stable systolic heart failure patients: a randomised, double-blind, cross-over, placebo-controlled intervention study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Regulation of hepatocyte thyroxine 5'-deiodinase by T3 and nuclear receptor coactivators as a model of the sick euthyroid syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Pericardial decompression syndrome in a patient with hypothyroidism presenting as massive pericardial effusion: a case report and review of related literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Pericardial effusion in primary hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Effusions into body cavities in hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Echocardiographic epicardial fat thickness and coronary artery disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Effects of restoration of the euthyroid state on epicardial adipose tissue and carotid intima media thickness in subclinical hypothyroid patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Evaluation of epicardial fat tissue thickness in patients with Hashimoto thyroiditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Cardiopulmonary bypass: a low T4 and T3 syndrome with blunted thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome".

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Impact of triiodothyronine on the survival of high-risk patients undergoing open heart surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The low triiodothyronine syndrome: a strong predictor of low cardiac output and death in patients undergoing coronary artery bypass grafting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Clinical review: thyroid hormone replacement in children after cardiac surgery--is it worth a try?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Negative association between free triiodothyronine level and international normalized ratio in euthyroid subjects with acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Sick euthyroid syndrome is associated with poor prognosis in patients with ST segment elevation myocardial infarction undergoing primary percutaneous intervention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Prevalence of Subclinical Hypothyroidism among Patients with Acute Myocardial Infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Non-thyroidal illness in the ICU: a syndrome with different faces

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Dangerous dogmas in medicine: the nonthyroidal illness syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

A low fT3 level as a prognostic marker in patients with acute myocardial infarctions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction: a strong association?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Cardioprotection and thyroid hormones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

The thyroid hormone receptor-beta agonist GC-1 induces cell proliferation in rat liver and pancreas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

A proliferative burst during preadolescence establishes the final cardiomyocyte number.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Pathophysiology of myocardial injury and remodeling: implications for molecular imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Left ventricular remodeling after acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Impaired oxidative metabolism and calcium mishandling underlie cardiac dysfunction in a rat model of post-acute isoproterenol-induced cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone represses protein kinase C isoform expression and activity in rat cardiac myocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone improves postischaemic recovery of function while limiting apoptosis: a new therapeutic approach to support hemodynamics in the setting of ischaemia-reperfusion?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone and cardioprotection: study of p38 MAPK and JNKs during ischaemia and at reperfusion in isolated rat heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Dose-dependent effects of thyroid hormone on post-ischemic cardiac performance: potential involvement of Akt and ERK signalings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Triiodothyronine prevents cardiac ischemia/reperfusion mitochondrial impairment and cell loss by regulating miR30a/p53 axis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormones improve cardiac function and decrease expression of pro-apoptotic proteins in the heart of rats 14 days after infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Improvement of left ventricular remodeling after myocardial infarction with eight weeks L-thyroxine treatment in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Safe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse Effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormones as modulators of immune activities at the cellular level

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Ligand binding to integrins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Tri-iodothyronine regulates the production of interleukin-6 and interleukin-8 in human bone marrow stromal and osteoblast-like cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Control of dendritic cell maturation and function by triiodothyronine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Relationship between triiodothyronine and proinflammatory cytokines in chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Involvement of circulating interleukin-6 and its receptor in the development of euthyroid sick syndrome in patients with acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Short term triiodo-L-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid replacement therapy and heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroxine in acute myocardial infarction (ThyrAMI) - levothyroxine in subclinical hypothyroidism post-acute myocardial infarction: study protocol for a randomised controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

Thyroid hormone and cardiac disease: from basic concepts to clinical application

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2016.174

[Subclinical hyperthyroidism and atrial fibrillation]

31 March 2020

1 reference

12 December 2020

The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries.

1 reference

12 December 2020

Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients.

1 reference

12 December 2020

Vascular degeneration in hypothyroidism.

1 reference

12 December 2020

Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats

1 reference

12 December 2020

Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment

1 reference

12 December 2020

Cardiovascular disease in Europe 2015: epidemiological update

1 reference

12 December 2020

Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism

1 reference

12 December 2020

Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature

1 reference

12 December 2020

The Coronary Drug Project --- Findings with Regard to Estrogen, Dextrothyroxine, Clofibrate and Niacin

1 reference

12 December 2020

Thyroid hormone replacement for subclinical hypothyroidism

1 reference

12 December 2020

The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans

1 reference

12 December 2020

Alterations in cardiac contractility and gene expression during low-T3 syndrome: prevention with T3.

1 reference

12 December 2020

Prevalence of echocardiographic criteria for the diagnosis of pulmonary hypertension in patients with Graves' disease: before and after antithyroid treatment

1 reference

12 December 2020

Molecular biological and biochemical characterization of the human type 2 selenodeiodinase

1 reference

12 December 2020

Correlation of circulating interleukin-10 with thyroid hormone in acute myocardial infarction

1 reference

12 December 2020

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

1 reference

12 December 2020

Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality

1 reference

12 December 2020

Hormonal regulation of cholesterol 7alpha-hydroxylase specific activity, mRNA levels, and transcriptional activity in vivo in the rat.

1 reference

12 December 2020

Blood coagulation and fibrinolytic activity in hypothyroidism

1 reference

12 December 2020

Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study

1 reference

12 December 2020

The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group

1 reference

12 December 2020

DITPA stimulates bFGF, VEGF, angiopoietin, and Tie-2 and facilitates coronary arteriolar growth

1 reference

12 December 2020

Tumor necrosis factor-alpha-induced expression of heat shock protein 72 in adult feline cardiac myocytes

1 reference

12 December 2020